ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly commercial paper outstanding ($M) ($M)
Form 10-Q / 10-K Financial Instruments & Debt Note
Latest, Q2 2026
5,284
Period ended Jun 30, 2026
Change on a year earlier
+29.1%
4,092 in Q2 2025
History
21 quarters
Since Q4 2016
Sources
19
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Commercial paper outstanding ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 5,284 | +29.1% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 1,775 | -28.7% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2025 | Dec 31, 2025 | 0 | -100.0% | Form 10-Q (filed 2026-08-05) ↗ |
| Q3 2025 | Sep 30, 2025 | 0 | -100.0% | Form 10-Q (filed 2025-10-30) ↗ |
| Q2 2025 | Jun 30, 2025 | 4,092 | -6.7% | Form 10-Q (filed 2025-08-07) ↗ |
| Q1 2025 | Mar 31, 2025 | 2,489 | +152.8% | Form 10-Q (filed 2025-05-01) ↗ |
| Q4 2024 | Dec 31, 2024 | 4,338 | -29.9% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2024 | Sep 30, 2024 | 1,295 | -18.8% | Form 10-Q (filed 2024-10-30) ↗ |
| Q2 2024 | Jun 30, 2024 | 4,385 | – | Form 10-Q (filed 2024-08-08) ↗ |
| Q1 2024 | Mar 31, 2024 | 985 | – | Form 10-Q (filed 2024-04-30) ↗ |
| Q4 2023 | Dec 31, 2023 | 6,189 | +313.2% | Form 10-K (filed 2025-02-19) ↗ |
| Q3 2023 | Sep 30, 2023 | 1,595 | – | Form 10-Q (filed 2023-11-02) ↗ |
| Q2 2023 | Jun 30, 2023 | 0 | – | Form 10-Q (filed 2023-08-08) ↗ |
| Q1 2023 | Mar 31, 2023 | 0 | – | Form 10-Q (filed 2023-04-27) ↗ |
| Q4 2022 | Dec 31, 2022 | 1,498 | – | Form 10-K (filed 2024-02-21) ↗ |
| Q4 2021 | Dec 31, 2021 | 0 | – | Form 10-K (filed 2023-02-22) ↗ |
| Q4 2020 | Dec 31, 2020 | 0 | -100.0% | Form 10-K (filed 2021-02-17) ↗ |
| Q4 2019 | Dec 31, 2019 | 1,494 | +199.5% | Form 10-K (filed 2021-02-17) ↗ |
| Q4 2018 | Dec 31, 2018 | 499 | -81.5% | Form 10-K (filed 2020-02-19) ↗ |
| Q4 2017 | Dec 31, 2017 | 2,697 | +107.6% | Form 10-K (filed 2019-02-19) ↗ |
| Q4 2016 | Dec 31, 2016 | 1,299 | – | Form 10-K (filed 2018-02-20) ↗ |
Cite this data
StockData. (2026). Eli Lilly Commercial paper outstanding ($M) ($M), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/cp_outstanding
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.